Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

Global Mantle Cell Lymphoma Therapeutics Market: About this market

Mantle cell lymphoma therapeutics are available in combination therapy and monotherapy. Technavio’s mantle cell lymphoma therapeutics market analysis considers sales from the combination therapy and monotherapy segments. Our analysis also considers the sales of mantle cell lymphoma therapeutics in Asia, Europe, North America, and ROW. In 2018, the combination therapy segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the reduced drug resistance and rising development and commercialization of combination therapies will significantly help the market segment in maintaining its leading position. Also, our global mantle cell lymphoma therapeutics report has observed market growth factors such as recent approvals, introduction of targeted therapies, and growth of geriatric population. However, adverse effects of available therapeutics, limited access to treatment, and presence of stringent regulations may hamper the growth of the mantle cell lymphoma therapeutics industry over the forecast period.

Global Mantle Cell Lymphoma Therapeutics Market: Overview

Recent approvals

The significant unmet need for the treatment of mantle cell lymphoma has given the market vendors scope to develop reliable therapeutics. The rising formulation of therapeutics has prompted many approvals in the last few years, increasing the sales of vendors. As a result, recent approvals will lead to the expansion of the mantle cell lymphoma therapeutics market at a CAGR of over 7% during the forecast period.

Advent of novel therapies

Vendors are formulating advanced therapeutics to cater to the market demand. For instance, kinase inhibitors and gene therapies exhibit high efficacy, increasing their demand. Therefore, this trend will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global mantle cell lymphoma therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global mantle cell lymphoma therapeutics market is concentrated. Technavio’s robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading mantle cell lymphoma therapeutics manufacturers, which include Allergan Plc, AstraZeneca Plc, Celgene Corp., Johnson & Johnson Services Inc., and Takeda Pharmaceutical Co. Ltd.

Also, the mantle cell lymphoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


Companies Mentioned

Allergan Plc, AstraZeneca Plc, Celgene Corp., Johnson & Johnson Services Inc., and Takeda Pharmaceutical Co. Ltd.

  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Combination therapy - Market size and forecast 2018-2023
      • Table Combination therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Combination therapy - Year-over-year growth 2019-2023 (%)
    • Monotherapy - Market size and forecast 2018-2023
      • Table Monotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Monotherapy - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Proportion of geriatric population in Asia 2007 and 2017
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Pipeline molecules
      • Table Growth in geriatric population 2013-2017 (%)
    • Market challenges
      • Table Side effects of drugs treating mantle cell lymphoma
      • Table Impact of drivers and challenges
  • Market trends
    • Advent of novel therapies
    • Research grants and funding
    • Special drug designations
      • Table Drug designations
      • Table Recently approved drug designations to drug candidates aimed to treat mantle cell lymphoma
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Allergan Plc
      • Table Allergan Plc - Vendor overview
      • Table Allergan Plc - Business segments
      • Table Allergan Plc - Organizational developments
      • Table Allergan Plc - Geographic focus
      • Table Allergan Plc - Segment focus
      • Table Allergan Plc - Key offerings
      • Table Allergan Plc - Key customers
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Vendor overview
      • Table AstraZeneca Plc - Product segments
      • Table AstraZeneca Plc - Organizational developments
      • Table AstraZeneca Plc - Geographic focus
      • Table AstraZeneca Plc - Key offerings
      • Table AstraZeneca Plc - Key customers
    • Celgene Corp.
      • Table Celgene Corp. - Vendor overview
      • Table Celgene Corp. - Business segments
      • Table Celgene Corp. - Organizational developments
      • Table Celgene Corp. - Geographic focus
      • Table Celgene Corp. - Key offerings
      • Table Celgene Corp. - Key customers
    • Johnson & Johnson Services Inc.
      • Table Johnson & Johnson Services Inc. - Vendor overview
      • Table Johnson & Johnson Services Inc. - Business segments
      • Table Johnson & Johnson Services Inc. - Organizational developments
      • Table Johnson & Johnson Services Inc. - Geographic focus
      • Table Johnson & Johnson Services Inc. - Segment focus
      • Table Johnson & Johnson Services Inc. - Key offerings
      • Table Johnson & Johnson Services Inc. - Key customers
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Vendor overview
      • Table Takeda Pharmaceutical Co. Ltd. - Business segments
      • Table Takeda Pharmaceutical Co. Ltd. - Organizational developments
      • Table Takeda Pharmaceutical Co. Ltd. - Geographic focus
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
      • Table Takeda Pharmaceutical Co. Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook